Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA)

205 filings reported holding DNA - Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share as of Q1 2025.
Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 32.3M shares of 48.3M outstanding shares and own 66.83% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (3.58M shares), BAILLIE GIFFORD & CO (3.35M shares), VANGUARD GROUP INC (2.13M shares), Anchorage Capital Group, L.L.C. (1.75M shares), Erste Asset Management GmbH (1.65M shares), EcoR1 Capital, LLC (1.46M shares), MILLENNIUM MANAGEMENT LLC (1.43M shares), Legal & General Group Plc (1.42M shares), BlackRock, Inc. (1.24M shares), and Opaleye Management Inc. (1.2M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.